| | |
| Legal status | |
|---|---|
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| Chemical and physical data | |
| Formula | C18H23N3O3 |
| Molar mass | 329.400 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Para-nitroazaprocin is an opioid designer drug which is the 4'-nitro derivative of azaprocin. It has around 25x the potency of morphine, [1] and was made a Class A drug in the UK in May 2024. [2]